MET and plasma cell myeloma: To assess whether c‐met inhibition can be used for MM treatment, we first studied the prevalence of c‐met overexpression in MM by analysing the publicly available gene expression profiling (GEP) database of myeloma, GSE 5900 and GSE 2658.